Median Technologies, the Imaging Phenomics Company, and inVentiv Health, a biopharmaceutical professional services company, announ
Median, a leading services provider for image interpretation and management in oncology trials, will complement inVentiv
For early stage studies, Median will provide inVentiv clients with integrated imaging services to maximize access to meaningful and appropriate imaging biomarkers. This automated, standardized image management and endpoint review ensures clients receive easy access to the highest quality data to make fast, informed decisions. For late stage studies, Median provides core technology that has been cleared by the FDA and other regulatory bodies, providing high data integrity, reliability and transparency.
inVentiv and Median will also provide advanced solutions that enhance the value of client services through the development of customer account technology, and the av